Elevance Health: CMS Rate Surprise Hands Insurers a Rebound - Buy the Pullback
CMS's 2.48% Medicare Advantage capitation boost (4.98% including risk-score trends) materially improves 2027 revenue outlook for insurers. Elevance combines attractive valuation (P/E ~12), healthy free cash flow ($3.17B), and constructive technicals after the gap-up. This trade targets a return toward $360 with a stop under $288 - a measured swing …